Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?
Radiother Oncol
; 169: 51-56, 2022 04.
Article
in En
| MEDLINE
| ID: mdl-35151715
Full text:
1
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Brachytherapy
/
Radiosurgery
Type of study:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
/
Male
Language:
En
Journal:
Radiother Oncol
Year:
2022
Type:
Article
Affiliation country:
Canada